Leading the Way in Life Science Technologies

GEN Exclusives

More »

Columns

More »

For full access to this article login to GEN Select now.

May 1, 2014 (Vol. 34, No. 9)

Arecor Employs Excipients for Biologics Stability

Reformulations Significantly Improve Stability of Proteins and Peptides

  • When biologics took center stage in the pharmaceutical development pipeline, Thomas Reese Saylor, president and CEO of Arecor, realized that developers needed new approaches ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.
    •  


Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »